Showing results (141-150 of 150) with videos related to
Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 150 results.
Journal of Neuro-Oncology|June 23, 2020
Reduced-dose craniospinal irradiation is feasible for standard-risk adult medulloblastoma patientsMaura Massimino, Marie Pierre Sunyach, Francesco Barretta, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2025
Is There a Role for Mifamurtide in Nonmetastatic High-Grade Osteosarcoma? Results From the Italian Sarcoma Group (ISG/OS-2) and Spanish Sarcoma Group (GEIS-33) TrialsEmanuela Palmerini, Cristina Meazza, Angela Tamburini, et al.Neuro-Oncology|September 27, 2024
Long-term outcome of the Milano-hyperfractionated accelerated radiotherapy strategy for high-risk medulloblastoma, including the impact of molecular subtypeMaura Massimino, Francesco Barretta, Chiara Dossena, et al.Critical Reviews in Oncology/Hematology|May 8, 2026
Management of Atypical Cartilaginous Tumors (ACT) An Italian Sarcoma Group Consensus DocumentDomenico A Campanacci, Giacomo Giulio Baldi, Roberto Scanferla, et al.Journal of Translational Medicine|February 13, 2024
From the identification of actionable molecular targets to the generation of faithful neuroblastoma patient-derived preclinical modelsMario Capasso, Chiara Brignole, Vito A Lasorsa, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 9, 2020
Influence of Surgical Excision on the Survival of Patients With Stage 4 High-Risk Neuroblastoma: A Report From the HR-NBL1/SIOPEN StudyKeith Holmes, Ulrike Pötschger, Andrew D J Pearson, et al.Cancer Research Communications|March 25, 2026
Mapping genomic heterogeneity in paediatric and adolescent-young adult sarcomas: insights from the Italian SAR-GEN2016 and SAR-GEN_ITA prospective multicenter trialsElisa Tirtei, Valeria Difilippo, Federico Divincenzo, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 11, 2021
Frequency and Prognostic Impact of <i>ALK</i> Amplifications and Mutations in the European Neuroblastoma Study Group (SIOPEN) High-Risk Neuroblastoma Trial (HR-NBL1)Angela Bellini, Ulrike Pötschger, Virginie Bernard, et al.Cancer Treatment Reviews|April 11, 2024
Clinical recommendations for treatment of localized angiosarcoma: A consensus paper by the Italian Sarcoma GroupElena Palassini, Giacomo Giulio Baldi, Sara Sulfaro, et al.Critical Reviews in Oncology/Hematology|September 25, 2025
Extended molecular profiling in mesenchymal tumors: a consensus paper from the Italian Sarcoma GroupLorenzo D'Ambrosio, Marta Sbaraglia, Alessandra Merlini, et al.Pageof 15